title: Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumour models.
abstract: Polybutylcyanoacrylate (PBCA) nanoparticles were prepared and loaded with mitoxantrone, a highly effective anticancer drug. The proportion of mitoxantrone bound to the particles was analysed to be about 15 per cent of the initial drug concentration with the incorporation method and about 8 per cent with the adsorption method. Selected nanoparticle formulations were tested in leukaemia- or melanoma-bearing mice after intravenous injection. Efficacy and toxicity of mitoxantrone nanoparticles were compared with a drug solution and with a mitoxantrone-liposome formulation (small unilamellar vesicles with a negative surface charge). Furthermore, influence of an additional coating surfactant, poloxamine 1508, which has been shown to change body distribution of other polymeric nanoparticles, was investigated. It was shown that PBCA nanoparticles and liposomes influenced the efficacy of mitoxantrone in cancer therapy differently: liposomes prolonged survival time in P388 leukaemia, whereas nanoparticles led to a significant tumour volume reduction at the B16 melanoma. Neither nanoparticles nor liposomes were able to reduce the toxic side-effects caused by mitoxantrone, namely leucocytopenia. A slight additional influence of the coating surfactant was observed with only one preparation.
authors.affiliation: Institut für Pharmazeutische Technologie der J. W. Goethe-Universität, Frankfurt, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Beck
authors.forename: J
authors.initials: J
authors.lastname: Kreuter
authors.forename: R
authors.initials: R
authors.lastname: Reszka
authors.forename: I
authors.initials: I
authors.lastname: Fichtner
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004659:Enbucrilate / Q000494:pharmacology*; D005260:Female; D007941:Leukemia P388 / Q000188:drug therapy*; D008081:Liposomes; D008546:Melanoma, Experimental / Q000188:drug therapy*; D051379:Mice; D008815:Mice, Inbred Strains; D008942:Mitoxantrone / Q000008:administration & dosage* / Q000494:pharmacology / Q000633:toxicity; D010316:Particle Size; D011108:Polymers / Q000494:pharmacology; D014462:Ultrafiltration
chemical_list: D008081:Liposomes; D011108:Polymers; D008942:Mitoxantrone; D004659:Enbucrilate